Skip to content

The effect of the Persian medicine product based on colchicum on knee osteoarthritis

Investigating the effect of the Persian medicine product based on colchicum compared to placebo on pain and morning stiffness in patients with knee osteoarthritis: a triple-blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230628058606N1
Enrollment
70
Registered
2023-08-07
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: 35 patients receiving capsules containing colchicum, ashwagandha and mustic gum twice a day for 42 days. Intervention 2: Control group: 35 patients receiving capsul

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age of 45-75 years old Diagnosis of knee osteoarthritis based on the criteria of the American College of Rheumatology, which is confirmed by a rheumatology specialist. The presence of moderate knee pain within 24 hours based on linear-visual pain scale (VAS) between 3.5 and 7.5 cm. Completing the inform consent form

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding Lack of physical and mental ability to answer questions Occurrence of debilitating disease during treatment History of allergy to herbal medicines use of alcohol or drug abuse History of systemic diseases such as heart failure, kidney failure and uncontrolled blood pressure Routine use of oral analgesic (except 500 mg oral acetaminophen daily) Consuming nutritional and medicinal supplements on a regular and daily basis Intra-articular injection of corticosteroid drugs during the last six months

Design outcomes

Primary

MeasureTime frame
Knee pain intensity. Timepoint: at the begining of intervention and 21 and 42 days after the intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire, visual analogue scale (VAS) questionnaire.;Morning stiffness of knee. Timepoint: at the begining of intervention and 21 and 42 days after the intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire.;Physical performance. Timepoint: at the begining of intervention and 21 and 42 days after the intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire.;Heel to thigh distance. Timepoint: at the begining of intervention and 21 and 42 days after the intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Karegar-Borzi

Kerman University of Medical Sciences

kbhossein@yahoo.com+98 34 3133 6185

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026